Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-01-28 @ 6:34 PM
Study NCT ID:
NCT00398320
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2006-10-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
Sponsor:
Organization: